Feasibility of RUS Lung in MITS
HTL-001
Feasibility and Efficacy of Surgical Navigation 'RUS Lung' in Patients Undergoing Minimally Invasive Thoracic Surgery (MITS) Segmentectomy for Lung Cancer: a Multicenter Prospective Observational Study With a Propensity-score Matching Analysis
1 other identifier
interventional
34
1 country
1
Brief Summary
This sponsor-initiated prospective observational study aims to demonstrate the feasibility and efficacy of RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS). The trial will enroll 36 patients who undergo video-assisted or robot-assisted thoracoscopic surgery using RUS Lung. The study will be conducted across two medical centers."
- Investigational Medical Device: RUS Lung (Endoscopic Imaging Treatment Planning Software)
- Clinical Trial duration: 12 months from IRB approval
- Target number of subjects: Total of 36 participants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable lung-cancer
Started May 2025
Shorter than P25 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedStudy Start
First participant enrolled
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2025
CompletedSeptember 3, 2025
August 1, 2025
16 days
April 9, 2025
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The concordance rate of tumor location across CT, RUS Lung, and surgery
Overall feasibility of the RUS Lung system will be evaluated by 3 factors as below. 1. CT turn-around time: the duration between uploading of preoperative CT and downloading the 3D model file 2. The stability of the RUS Lung system 3. The concordance rate of tumor location across CT, RUS Lung, and surgery
The operative day (operative day ± 5 days)
Secondary Outcomes (1)
The degree of consistency between surgical planning using the RUS lung system and actual surgical findings.
From enrollment to the end of treatment at 2 weeks
Study Arms (1)
RUS Group
EXPERIMENTALPatients undergo video-assisted or robot-assisted thoracoscopic surgery using RUS Lung software.
Interventions
The RUS Lung is an endoscopic imaging treatment planning software program. It creates a patient-specific simulation of the thoracic surgical environments, allowing for the visualization of tumor, bronchovascular structures and thoracic organs during the surgical planning process and the operation. RUS Lung utilizes preoperative CT images of the patients to segment tumor, organs, blood vessels, and bronchus and reconstructs them into a 3D model. Although there is no direct intervention on the patient, the surgeon uses RUS Lung as a surgical navigation tool to simulate the surgery before performing the actual procedure.
Eligibility Criteria
You may qualify if:
- Individuals who were diagnosed with lung caner (tumor size≤3cm)
- Individuals aged 19 or older
- Individuals who who are able to undergo CT imaging according to the established protocol
- Individuals who have voluntarily given written consent to participate in this clinical trial
You may not qualify if:
- Vulnerable subjects
- Individuals who who are not able to undergo CT imaging according to the established protocol
- Individuals who are expected to have severe adhesions
- Individuals who are unable to follow the study procedures and are deemed inappropriate for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hutom Corplead
- Severance Hospitalcollaborator
- Ajou University School of Medicinecollaborator
Study Sites (1)
Severance Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chang Young Lee, M.D.,Ph.D.
Severance Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2025
First Posted
May 1, 2025
Study Start
May 12, 2025
Primary Completion
May 28, 2025
Study Completion
August 11, 2025
Last Updated
September 3, 2025
Record last verified: 2025-08